These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 18423383

  • 1. Brain oxidative stress in a triple-transgenic mouse model of Alzheimer disease.
    Resende R, Moreira PI, Proença T, Deshpande A, Busciglio J, Pereira C, Oliveira CR.
    Free Radic Biol Med; 2008 Jun 15; 44(12):2051-7. PubMed ID: 18423383
    [Abstract] [Full Text] [Related]

  • 2. Acetyl-L-carnitine-induced up-regulation of heat shock proteins protects cortical neurons against amyloid-beta peptide 1-42-mediated oxidative stress and neurotoxicity: implications for Alzheimer's disease.
    Abdul HM, Calabrese V, Calvani M, Butterfield DA.
    J Neurosci Res; 2006 Aug 01; 84(2):398-408. PubMed ID: 16634066
    [Abstract] [Full Text] [Related]

  • 3. Early melatonin supplementation alleviates oxidative stress in a transgenic mouse model of Alzheimer's disease.
    Feng Z, Qin C, Chang Y, Zhang JT.
    Free Radic Biol Med; 2006 Jan 01; 40(1):101-9. PubMed ID: 16337883
    [Abstract] [Full Text] [Related]

  • 4. Targeting alzheimer amyloid plaques in vivo.
    Wengenack TM, Curran GL, Poduslo JF.
    Nat Biotechnol; 2000 Aug 01; 18(8):868-72. PubMed ID: 10932157
    [Abstract] [Full Text] [Related]

  • 5. Plaque-derived oxidative stress mediates distorted neurite trajectories in the Alzheimer mouse model.
    Garcia-Alloza M, Dodwell SA, Meyer-Luehmann M, Hyman BT, Bacskai BJ.
    J Neuropathol Exp Neurol; 2006 Nov 01; 65(11):1082-9. PubMed ID: 17086105
    [Abstract] [Full Text] [Related]

  • 6. Behavioral stress accelerates plaque pathogenesis in the brain of Tg2576 mice via generation of metabolic oxidative stress.
    Lee KW, Kim JB, Seo JS, Kim TK, Im JY, Baek IS, Kim KS, Lee JK, Han PL.
    J Neurochem; 2009 Jan 01; 108(1):165-75. PubMed ID: 19012747
    [Abstract] [Full Text] [Related]

  • 7. Galantamine protects against oxidative stress induced by amyloid-beta peptide in cortical neurons.
    Melo JB, Sousa C, Garção P, Oliveira CR, Agostinho P.
    Eur J Neurosci; 2009 Feb 01; 29(3):455-64. PubMed ID: 19222556
    [Abstract] [Full Text] [Related]

  • 8. A new insight on Al-maltolate-treated aged rabbit as Alzheimer's animal model.
    Bharathi, Shamasundar NM, Sathyanarayana Rao TS, Dhanunjaya Naidu M, Ravid R, Rao KS.
    Brain Res Rev; 2006 Sep 01; 52(2):275-92. PubMed ID: 16782202
    [Abstract] [Full Text] [Related]

  • 9. Early vitamin E supplementation in young but not aged mice reduces Abeta levels and amyloid deposition in a transgenic model of Alzheimer's disease.
    Sung S, Yao Y, Uryu K, Yang H, Lee VM, Trojanowski JQ, Praticò D.
    FASEB J; 2004 Feb 01; 18(2):323-5. PubMed ID: 14656990
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Melatonin prevents amyloid protofibrillar induced oxidative imbalance and biogenic amine catabolism.
    Gunasingh MJ, Philip JE, Ashok BS, Kirubagaran R, Jebaraj WC, Davis GD, Vignesh S, Dhandayuthapani S, Jayakumar R.
    Life Sci; 2008 Jul 18; 83(3-4):96-102. PubMed ID: 18590917
    [Abstract] [Full Text] [Related]

  • 12. Increased oxidative stress and astrogliosis responses in conditional double-knockout mice of Alzheimer-like presenilin-1 and presenilin-2.
    Zhu M, Gu F, Shi J, Hu J, Hu Y, Zhao Z.
    Free Radic Biol Med; 2008 Nov 15; 45(10):1493-9. PubMed ID: 18822370
    [Abstract] [Full Text] [Related]

  • 13. Progranulin expression correlates with dense-core amyloid plaque burden in Alzheimer disease mouse models.
    Pereson S, Wils H, Kleinberger G, McGowan E, Vandewoestyne M, Van Broeck B, Joris G, Cuijt I, Deforce D, Hutton M, Van Broeckhoven C, Kumar-Singh S.
    J Pathol; 2009 Oct 15; 219(2):173-81. PubMed ID: 19557827
    [Abstract] [Full Text] [Related]

  • 14. Involvement of oxidative stress in Alzheimer disease.
    Nunomura A, Castellani RJ, Zhu X, Moreira PI, Perry G, Smith MA.
    J Neuropathol Exp Neurol; 2006 Jul 15; 65(7):631-41. PubMed ID: 16825950
    [Abstract] [Full Text] [Related]

  • 15. Vitamin E in neurodegenerative disorders: Alzheimer's disease.
    Kontush K, Schekatolina S.
    Ann N Y Acad Sci; 2004 Dec 15; 1031():249-62. PubMed ID: 15753151
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Phosphorylated tau in neuritic plaques of APP(sw)/Tau (vlw) transgenic mice and Alzheimer disease.
    Pérez M, Morán MA, Ferrer I, Avila J, Gómez-Ramos P.
    Acta Neuropathol; 2008 Oct 15; 116(4):409-18. PubMed ID: 18679696
    [Abstract] [Full Text] [Related]

  • 18. An aluminum-based rat model for Alzheimer's disease exhibits oxidative damage, inhibition of PP2A activity, hyperphosphorylated tau, and granulovacuolar degeneration.
    Walton JR.
    J Inorg Biochem; 2007 Sep 15; 101(9):1275-84. PubMed ID: 17662457
    [Abstract] [Full Text] [Related]

  • 19. Altered oxidant-mediated intraneuronal zinc mobilization in a triple transgenic mouse model of Alzheimer's disease.
    Sensi SL, Rapposelli IG, Frazzini V, Mascetra N.
    Exp Gerontol; 2008 May 15; 43(5):488-92. PubMed ID: 18068923
    [Abstract] [Full Text] [Related]

  • 20. Protection against cognitive deficits and markers of neurodegeneration by long-term oral administration of melatonin in a transgenic model of Alzheimer disease.
    Olcese JM, Cao C, Mori T, Mamcarz MB, Maxwell A, Runfeldt MJ, Wang L, Zhang C, Lin X, Zhang G, Arendash GW.
    J Pineal Res; 2009 Aug 15; 47(1):82-96. PubMed ID: 19538338
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.